chr18-45734273-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PVS1_StrongPP5_ModerateBS2_Supporting

The NM_015865.7(SLC14A1):​c.342-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00024 in 1,613,980 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: 𝑓 0.00046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 7 hom. )

Consequence

SLC14A1
NM_015865.7 splice_acceptor, intron

Scores

4
1
2
Splicing: ADA: 0.9999
2

Clinical Significance

Likely pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 8.88
Variant links:
Genes affected
SLC14A1 (HGNC:10918): (solute carrier family 14 member 1 (Kidd blood group)) The protein encoded by this gene is a membrane transporter that mediates urea transport in erythrocytes. This gene forms the basis for the Kidd blood group system. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.11025641 fraction of the gene. Cryptic splice site detected, with MaxEntScore 3.7, offset of 1, new splice context is: tgtgtctcttgccccacaAGtca. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
PP5
Variant 18-45734273-G-A is Pathogenic according to our data. Variant chr18-45734273-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 17718.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 7 BG geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC14A1NM_015865.7 linkc.342-1G>A splice_acceptor_variant, intron_variant Intron 4 of 9 ENST00000321925.9 NP_056949.4 Q13336-1G0W2N5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC14A1ENST00000321925.9 linkc.342-1G>A splice_acceptor_variant, intron_variant Intron 4 of 9 1 NM_015865.7 ENSP00000318546.4 Q13336-1

Frequencies

GnomAD3 genomes
AF:
0.000454
AC:
69
AN:
152094
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0104
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000819
AC:
206
AN:
251418
AF XY:
0.000817
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0107
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000218
AC:
318
AN:
1461768
Hom.:
7
Cov.:
32
AF XY:
0.000197
AC XY:
143
AN XY:
727182
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
AC:
3
AN:
33478
Gnomad4 AMR exome
AF:
0.0000447
AC:
2
AN:
44724
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
26136
Gnomad4 EAS exome
AF:
0.00464
AC:
184
AN:
39696
Gnomad4 SAS exome
AF:
0.0000116
AC:
1
AN:
86250
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
53408
Gnomad4 NFE exome
AF:
0.00000180
AC:
2
AN:
1111924
Gnomad4 Remaining exome
AF:
0.00209
AC:
126
AN:
60384
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000460
AC:
70
AN:
152212
Hom.:
0
Cov.:
32
AF XY:
0.000443
AC XY:
33
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.0000482
AC:
0.0000481556
AN:
0.0000481556
Gnomad4 AMR
AF:
0.000589
AC:
0.00058862
AN:
0.00058862
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.0105
AC:
0.010453
AN:
0.010453
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000147
AC:
0.000014702
AN:
0.000014702
Gnomad4 OTH
AF:
0.00190
AC:
0.00189573
AN:
0.00189573
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000535
Hom.:
5
Bravo
AF:
0.000495
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000700
AC:
85
Asia WGS
AF:
0.00722
AC:
25
AN:
3478

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Jk-null variant Pathogenic:1
May 22, 1998
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

SLC14A1-related disorder Pathogenic:1
May 17, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The SLC14A1 c.342-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant is predicted to disrupt the consensus AG splice-acceptor site in SLC14A1 near the intron 4 – exon 5 boundary and has been reported in affected individuals (Lucien et al. 1998. PubMed ID: 9582331; Hou et al. 2020. PubMed ID: 31980526). SLC14A1 encodes a urea transporter that is found in the kidney and on red blood cells. The blood type Jk-null is defined by a loss of the SLC14A1 protein on red blood cells. The Jk-null blood type is not defined by any obvious clinical presentation, but patients may have a urine concentration defect (Sands et al. 1992. PubMed ID: 1498276). Patients with two deleterious variants in a trans configuration may have the Jk-null phenotype and could develop alloantibodies against the Jk antigen during pregnancy or after transfusion with Jk+ red blood cells that may cause hemolysis (Lucien et al. 2002. PubMed ID: 11807016). This variant is reported in 1.1% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-43314238-G-A). Variants that disrupt the consensus splice acceptor site in SLC14A1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.040
T
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
26
DANN
Uncertain
0.99
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.85
FATHMM_MKL
Pathogenic
0.98
D
GERP RS
5.5
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.95
SpliceAI score (max)
0.93
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.93
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs78937798; hg19: chr18-43314238; API